Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Gratz, Silvia
and
Simpson, George
1990.
Neuroleptic malignant syndrome.
British Journal of Psychiatry,
Vol. 157,
Issue. 4,
p.
617.
Granville-Grossman, K
1990.
Psychiatry.
Postgraduate Medical Journal,
Vol. 66,
Issue. 779,
p.
699.
Sagar, S M
1991.
Neuroleptic Malignant Syndrome: A Diagnostic Dilemma.
Journal of the Royal Society of Medicine,
Vol. 84,
Issue. 8,
p.
500.
Adityanjee
1991.
The Myth of Elevated Serum Creatine Phosphokinase Level and Neuroleptic Malignant Syndrome.
British Journal of Psychiatry,
Vol. 158,
Issue. 5,
p.
706.
Lazarus, Arthur
Caroff, Stanley N
and
Mann, Stephan C
1991.
Beyond NMS: Management After the Acute Episode.
Psychiatric Annals,
Vol. 21,
Issue. 3,
p.
165.
Watts, Darryl
1991.
Neuroleptic Malignant Syndrome in a Case of Acute Post-traumatic Psychosis.
British Journal of Psychiatry,
Vol. 159,
Issue. 2,
p.
277.
Velamoor, V.R.
Swamy, G.N.
and
Parmar, R.S.
1992.
Confusion, Agitation and Rigidity: Early Signs of Nms?.
The Canadian Journal of Psychiatry,
Vol. 37,
Issue. 4,
p.
280.
Allen, Judith M V
and
Monaghan, Clare E
1993.
Carbon monoxide poisoning and neuroleptic malignant syndrome.
Irish Journal of Psychological Medicine,
Vol. 10,
Issue. 3,
p.
155.
Velamoor, Vr
Swamy, Gn
Parmar, Late-Rs
Williamson, P
and
Caroff, Sn
1995.
Management of Suspected Neuroleptic Malignant Syndrome.
The Canadian Journal of Psychiatry,
Vol. 40,
Issue. 9,
p.
545.
Buckley, P F
and
Hutchinson, M
1995.
Neuroleptic malignant syndrome..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 58,
Issue. 3,
p.
271.
Berardi, Domenico
Amore, Mario
Keck, Paul E
Troia, Mario
and
Dell’Atti, Maddalena
1998.
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study.
Biological Psychiatry,
Vol. 44,
Issue. 8,
p.
748.
Christensen, Richard C
1998.
Recognizing early signs of neuroleptic malignant syndrome.
The American Journal of Emergency Medicine,
Vol. 16,
Issue. 1,
p.
95.
Marcus, Esther-Lee
Vass, Agnes
and
Zislin, Joseph
1999.
Marked Elevation of Serum Creatine Kinase Associated with Olanzapine Therapy.
Annals of Pharmacotherapy,
Vol. 33,
Issue. 6,
p.
697.
Factor, Stewart A.
2005.
Drug Induced Movement Disorders.
p.
174.
White, Suzanne R.
2005.
Acute Dystonic Reaction and the Neuroleptic Malignant Syndrome.
Journal of Pharmacy Practice,
Vol. 18,
Issue. 3,
p.
175.
Erermis, Serpil
Bildik, Tezan
Tamar, Muge
Gockay, Ahmet
Karasoy, Hatice
and
Ercan, Eyup Sabri
2007.
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Clinical Toxicology,
Vol. 45,
Issue. 3,
p.
277.
Lee, Joseph WY
2015.
Catatonia & Neuroleptic Malignant Syndrome.
Future Neurology,
Vol. 10,
Issue. 5,
p.
431.
eLetters
No eLetters have been published for this article.